Skip to main content

Table 8 Serum SOD and MDA in Xuan Bai Cheng Qi and control groups before and and after treatment

From: Xuan Bai Cheng Qi formula as an adjuvant treatment of acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs: a multicenter, randomized, double-blind, placebo-controlled clinical trial

Variables XBCQa(n = 20) Controla(n = 20) Treatment effectc(95% CI; P value)
  Day 1 (Baseline) Day 10 (End) Mean Db Day 1 (Baseline) Day 10 (End) Mean D  
SOD (U/mL) 20.56 (4.95) 28.54 (4.66) 7.98 (5.97) 21.90 (5.32) 23.24 (6.76) 1.33 (4.21) 6.09 (2.94, 9.23; < .001)
MDA (nmol/mL) 4.43 (1.52) 1.89 (0.52) -2.54 (1.65) 4.52 (1.44) 2.98 (1.45) -1.54 (0.94)b -1.07 (-1.55, -0.59; < .001)
  1. Abbreviations: CI confidence interval, MDA malondialdehyde, Mean D mean difference, SOD superoxide dismutase, XBCQ Xuan Bai Cheng Qi.
  2. aData presented as mean (SD).
  3. b P < .01: Change between pre-treatment and post-treatment (within group difference by paired t-test).
  4. cCovariance analysis estimate with 95% confidence interval for difference.